Clinical trials
Phase 2 trials in Mozambique
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 3 |
| Janssen Vaccines & Prevention B.V. | 2 |
| Novartis Pharmaceuticals | 2 |
| ANRS, Emerging Infectious Diseases | 1 |
| Instituto Nacional de Saúde, Mozambique | 1 |
| International Vaccine Institute | 1 |
| Janssen Research & Development, LLC | 1 |
| Jomaa Pharma GmbH | 1 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 1 |
| Michael Hoelscher | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria | 5 |
| Malaria, Falciparum | 2 |
| COVID-19 | 1 |
| HIV Infections | 1 |
| Hemorrhagic Fever, Ebola | 1 |
| Hemorrhagic Fevers, Viral | 1 |
| Poliomyelitis | 1 |
| Tuberculosis | 1 |
| Tuberculosis, Meningeal | 1 |
| Tuberculosis, Multidrug-Resistant | 1 |
Trials
Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.